U.S. Gastroenterology Ambulatory Surgery Centers Market Size, Share & Trends Analysis Report By Ownership (Hospital-affiliated, Freestanding, Corporation-owned), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
U.S. Sun Care Market Growth & Trends
The U.S. sun care market size is expected to reach USD 21.44 billion by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing emphasis on personal health coupled with rising instances of skin care due to over exposure is giving momentum to the usage of organic sun care products thereby propelling the market growth.
Growing demand for organic sun care products including sunscreen is expected to drive the product’s demand. Furthermore, the rising demand for the organic products over non-organic sun care products owing to the elimination of synthetic chemicals is projected to fuel the market growth over the forecast period.
The rising e-commerce portals or websites result in an ease of the product purchase with diverse companies providing price discounts. In addition, the new entrants stand a chance to market their product and reach greater and targeted audiences. Moreover, the product is expected to register an increase in demand owing to rise in a number of these portals and end-user usage.
The industry is characterized by the presence of stringent regulatory frameworks associated with the chemical composition utilized in the production sun care products. Paraaminobenzoic acid (PABA) was used as a UV absorbing but it is banned owing to the chemical causing skin irritation and is currently swapped bya derivative of PABA, Padimate-O.
U.S. Sun Care Market Report Highlights
U.S. Sun Care Market Growth & Trends
The U.S. sun care market size is expected to reach USD 21.44 billion by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing emphasis on personal health coupled with rising instances of skin care due to over exposure is giving momentum to the usage of organic sun care products thereby propelling the market growth.
Growing demand for organic sun care products including sunscreen is expected to drive the product’s demand. Furthermore, the rising demand for the organic products over non-organic sun care products owing to the elimination of synthetic chemicals is projected to fuel the market growth over the forecast period.
The rising e-commerce portals or websites result in an ease of the product purchase with diverse companies providing price discounts. In addition, the new entrants stand a chance to market their product and reach greater and targeted audiences. Moreover, the product is expected to register an increase in demand owing to rise in a number of these portals and end-user usage.
The industry is characterized by the presence of stringent regulatory frameworks associated with the chemical composition utilized in the production sun care products. Paraaminobenzoic acid (PABA) was used as a UV absorbing but it is banned owing to the chemical causing skin irritation and is currently swapped bya derivative of PABA, Padimate-O.
U.S. Sun Care Market Report Highlights
- The sunscreen & sunblock segment dominated the market and accounted for the largest revenue share of 38.8% in 2023. There is a growing understanding that prolonged exposure to the sun can lead to premature aging, wrinkles, and age spots.
- The lotions segment dominated the market and accounted for a share of 42.7% in 2023. Consumers favor lotions for their ease of application, moisturizing properties, and ability to cater to various skin types
- The adult segment dominated the market and accounted for a share of 60.8% in 2023 due to increased awareness of the long-term consequences of sun exposure, including premature aging and skin cancer.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. GASTROENTEROLOGY AMBULATORY SURGERY CENTERS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. U.S. Gastroenterology Ambulatory Surgery Centers Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. U.S. GASTROENTEROLOGY AMBULATORY SURGERY CENTERS MARKET: OWNERSHIP ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. U.S. Gastroenterology Ambulatory Surgery Centers Market: Ownership Movement Analysis, 2023 & 2030 (USD Million)
4.3. Hospital-affiliated
4.3.1. Hospital-affiliated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Freestanding
4.4.1. Freestanding Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Corporation-owned
4.5.1. Corporation-owned Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. Recent Developments & Impact Analysis by Key Market Participants
5.2. Company Categorization
5.3. Company Heat Map Analysis
5.4. Company Profiles
5.4.1. TH Medical.
5.4.1.1. Participant’s Overview
5.4.1.2. Financial Performance
5.4.1.3. Product Benchmarking
5.4.1.4. Recent Developments/ Strategic Initiatives
5.4.2. GE Healthcare
5.4.2.1. Participant’s Overview
5.4.2.2. Financial Performance
5.4.2.3. Product Benchmarking
5.4.2.4. Recent Developments/ Strategic Initiatives
5.4.3. Universal Health Services, Inc.
5.4.3.1. Participant’s Overview
5.4.3.2. Financial Performance
5.4.3.3. Product Benchmarking
5.4.3.4. Recent Developments/ Strategic Initiatives
5.4.4. Covenant Physician Partners
5.4.4.1. Participant’s Overview
5.4.4.2. Financial Performance
5.4.4.3. Product Benchmarking
5.4.4.4. Recent Developments/ Strategic Initiatives
5.4.5. Regent Surgery
5.4.5.1. Participant’s Overview
5.4.5.2. Financial Performance
5.4.5.3. Product Benchmarking
5.4.5.4. Recent Developments/ Strategic Initiatives
5.4.6. Cardinal Health.
5.4.6.1. Participant’s Overview
5.4.6.2. Financial Performance
5.4.6.3. Product Benchmarking
5.4.6.4. Recent Developments/ Strategic Initiatives
5.4.7. Boston Scientific Corporation
5.4.7.1. Participant’s Overview
5.4.7.2. Financial Performance
5.4.7.3. Product Benchmarking
5.4.7.4. Recent Developments/ Strategic Initiatives
5.4.8. Olympus Corporation
5.4.8.1. Participant’s Overview
5.4.8.2. Financial Performance
5.4.8.3. Product Benchmarking
5.4.8.4. Recent Developments/ Strategic Initiatives
5.4.9. Koninklijke Philips NV
5.4.9.1. Participant’s Overview
5.4.9.2. Financial Performance
5.4.9.3. Product Benchmarking
5.4.9.4. Recent Developments/ Strategic Initiatives
5.4.10. Cook Medical
5.4.10.1. Participant’s Overview
5.4.10.2. Financial Performance
5.4.10.3. Product Benchmarking
5.4.10.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. U.S. GASTROENTEROLOGY AMBULATORY SURGERY CENTERS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. U.S. Gastroenterology Ambulatory Surgery Centers Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. U.S. GASTROENTEROLOGY AMBULATORY SURGERY CENTERS MARKET: OWNERSHIP ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. U.S. Gastroenterology Ambulatory Surgery Centers Market: Ownership Movement Analysis, 2023 & 2030 (USD Million)
4.3. Hospital-affiliated
4.3.1. Hospital-affiliated Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Freestanding
4.4.1. Freestanding Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Corporation-owned
4.5.1. Corporation-owned Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Others
4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. Recent Developments & Impact Analysis by Key Market Participants
5.2. Company Categorization
5.3. Company Heat Map Analysis
5.4. Company Profiles
5.4.1. TH Medical.
5.4.1.1. Participant’s Overview
5.4.1.2. Financial Performance
5.4.1.3. Product Benchmarking
5.4.1.4. Recent Developments/ Strategic Initiatives
5.4.2. GE Healthcare
5.4.2.1. Participant’s Overview
5.4.2.2. Financial Performance
5.4.2.3. Product Benchmarking
5.4.2.4. Recent Developments/ Strategic Initiatives
5.4.3. Universal Health Services, Inc.
5.4.3.1. Participant’s Overview
5.4.3.2. Financial Performance
5.4.3.3. Product Benchmarking
5.4.3.4. Recent Developments/ Strategic Initiatives
5.4.4. Covenant Physician Partners
5.4.4.1. Participant’s Overview
5.4.4.2. Financial Performance
5.4.4.3. Product Benchmarking
5.4.4.4. Recent Developments/ Strategic Initiatives
5.4.5. Regent Surgery
5.4.5.1. Participant’s Overview
5.4.5.2. Financial Performance
5.4.5.3. Product Benchmarking
5.4.5.4. Recent Developments/ Strategic Initiatives
5.4.6. Cardinal Health.
5.4.6.1. Participant’s Overview
5.4.6.2. Financial Performance
5.4.6.3. Product Benchmarking
5.4.6.4. Recent Developments/ Strategic Initiatives
5.4.7. Boston Scientific Corporation
5.4.7.1. Participant’s Overview
5.4.7.2. Financial Performance
5.4.7.3. Product Benchmarking
5.4.7.4. Recent Developments/ Strategic Initiatives
5.4.8. Olympus Corporation
5.4.8.1. Participant’s Overview
5.4.8.2. Financial Performance
5.4.8.3. Product Benchmarking
5.4.8.4. Recent Developments/ Strategic Initiatives
5.4.9. Koninklijke Philips NV
5.4.9.1. Participant’s Overview
5.4.9.2. Financial Performance
5.4.9.3. Product Benchmarking
5.4.9.4. Recent Developments/ Strategic Initiatives
5.4.10. Cook Medical
5.4.10.1. Participant’s Overview
5.4.10.2. Financial Performance
5.4.10.3. Product Benchmarking
5.4.10.4. Recent Developments/ Strategic Initiatives